Mandibular Overdenture Clinical Trial Comparing Parallel Sided and Tapered Dental Implants
Launched by UNIVERSITY OF WASHINGTON · Sep 2, 2017
Trial Information
Current as of May 05, 2025
Completed
Keywords
ClinConnect Summary
Titanium dental implants have been frequently used in the rehabilitation of edentulous patients. Implants may provide adequate denture stability, improve oral function and oral health related quality of life. There is evidence that implants supporting fixed and removable prostheses have excellent long term success rates. Factors such as implant surface characteristics, length, diameter and shape (parallel sided or tapered) may play and important role for the outcome of the treatment especially when the immediate loading protocol (loading of the implant the same day it is surgically placed) ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Be between 20 and 75 years of age
- • Be edentulous and have both upper and lower complete dentures
- • Present with American Society of Anesthesiologists (ASA) I or ASA II and no medical contraindications to implant treatment
- • Have adequate bone volume for placement of one (1) 4.0 mm diameter titanium dental implant with a minimum length of 10 mm in the symphyseal area (=midline) of the anterior mandible
- • Show absence of pathology such as cysts, infections in the gum tissue or bone and remaining roots.
- • Be able to understand the procedures and have a jaw opening range of 30 mm or more
- Exclusion Criteria:
- • Ongoing chemotherapy
- • Previous radiation to head/neck
- • Ongoing corticosteroid medication
- • Ongoing blood thinner medication
- • Ongoing medication with psychopharmacological drugs
- • History of alcohol/drug abuse
- • Remaining teeth/root tips
- • Poor quality /fractured/severely worn dentures that cannot be modified to fit the implant
- • Jaw opening range less than 30 mm
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Trial Officials
Mats Kronstrom, DDS, PhD
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials